Symonne Liu

University of Chicago · company speakers →

Symonne Liu graduated from the University of Chicago with a double major in Molecular Engineering and Biological Sciences. With a strong background in genetics, bioengineering, synthetic biology, and computational biology, Symonne has been actively involved in research projects spanning RNA interference pathways, retrovirus resistance mechanisms, and Schistosomiasis vaccine development. At the Golovkina Lab, Symonne investigates the mechanism of retrovirus infection in congenic mouse lines. As a leader in UChicago Gene Hackers, Symonne spearheaded the development of a novel virus-like particle vaccine for Schistosomiasis and collaborated with the NIH-funded Schistosomiasis Resource Center to conduct immunogenic studies. Symonne is also a prominent figure in the field of synthetic biology, leading a team that was nominated for the Best Project in Infectious Diseases at an international synthetic biology competition. Their expertise in designing and engineering biological systems has contributed to groundbreaking advancements in vaccine development and therapeutic strategies. Beyond research, Symonne has engaged in biomedical entrepreneurship and pharmacogenomics initiatives, bridging the gap between lab discoveries and clinical applications. As the founder and board member of the Chicagoland Virology Journal Club, they are dedicated to fostering STEM education and scientific communication on infectious diseases.

healthcare-servicespharma-biotechclinical-laboratory

Is this you? Claim this profile →

No public contact links on file.

Speaking history

World Congress on Infectious Diseases

25 June 2026 Barcelona, Spain “Virus-like-particle inspired particle-based Recombinant Schistosomiasis Vaccine (VIPR)”

Topics this speaker covers

healthcare-servicespharma-biotechclinical-laboratory

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →